Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ACTC > SEC Filings for ACTC > Form 8-K on 24-Oct-2013All Recent SEC Filings




Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, S

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

(e) At the 2013 annual meeting of stockholders of Advanced Cell Technology, Inc. (the "Company"), which was held on October 22, 2013 (the "2013 Annual Meeting"), the Company's stockholders approved a Certificate of Amendment to the Certificate of Incorporation (the "Certificate of Amendment"), which provides for an increase in the authorized number of shares of the Company's common stock, par value $0.001 per share, from 2,750,000,000 to 3,750,000,000. The Certificate of Amendment became effective upon its filing with the Secretary of State of the State of Delaware on October 24, 2013. The foregoing description of the Certificate of Amendment is qualified in its entirety by reference to the copy of the Certificate of Amendment filed as Exhibit 3.1 to this Form 8-K, which is incorporated by reference herein.

Item 5.07. Submission of Matters to a Vote of Security Holders.

At the 2013 Annual Meeting, the Company's stockholders approved the three proposals listed below. The proposals are described in detail in the Company's proxy statement for the 2013 Annual Meeting filed with the Securities and Exchange Commission on September 9, 2013 (the "Proxy Statement"). A total of 2,130,408,339 shares of common stock, representing 82.5% of the shares outstanding and eligible, to vote were represented, in person or by proxy, at the 2013 Annual Meeting, constituting a quorum. The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting as set forth in the Proxy Statement are as follows:

Proposal 1. To elect the following persons named as nominees for directors of the Company, to hold office until the next annual meeting of stockholders and until their respective successors have been duly elected and qualified:

     Gary Rabin      504,517,924 257,479,806  1,368,410,609
  Alan C. Shapiro    565,920,925 196,076,805  1,368,410,609
   Robert Langer     733,957,751 28,039,979   1,368,410,609
  Zohar Loshitzer    686,008,878 75,988,852   1,368,410,609
  Gregory D. Perry   722,985,165 39,012,565   1,368,410,609

Michael T. Heffernan 725,343,346 36,654,384 1,368,410,609

Proposal 2. To approve the Certificate of Amendment:

1,683,597,011 417,982,684 28,828,644 0

Proposal 3. To approve an amendment to the Certificate of Incorporation of the Company to effect a reverse stock split of the Company's common stock, par value $0.001 per share, at a ratio not less than one-for-thirty and not greater than one-for-one hundred, and reduce the number of authorized shares of the Company's common stock in the same proportion as the reverse split, with the exact ratio to be set within such range in the discretion of the Board of Directors without further approval or authorization of the Company's shareholders, provided that the Board of Directors determines to effect the reverse stock split and proportional reduction in authorized shares of common stock and such amendment is filed with the Secretary of State of Delaware no later than September 30, 2014:

1,800,667,397 319,788,879 9,952,063 0

Item 9.01 Financial Statements and Exhibits.

Exhibit No.   Description
    3.1       Certificate of Amendment to Certificate of Incorporation of Advanced
              Cell Technology, Inc. as filed on October 24, 2013 with the Delaware
              Secretary of State.

  Add ACTC to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ACTC - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.